WallStreetZenWallStreetZen

NASDAQ: LPTX
Leap Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for LPTX

Based on 3 analysts offering 12 month price targets for Leap Therapeutics Inc.
Min Forecast
$5.50+134.04%
Avg Forecast
$7.50+219.15%
Max Forecast
$9.00+282.98%

Should I buy or sell LPTX stock?

Based on 3 analysts offering ratings for Leap Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 33.33%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their LPTX stock forecasts and price targets.

LPTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-06-28
lockedlocked$00.00+00.00%2024-05-14
lockedlocked$00.00+00.00%2024-03-19

1 of 1

Forecast return on equity

Is LPTX forecast to generate an efficient return?
Company
-83.2%
Industry
73.55%
Market
80.58%
LPTX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is LPTX forecast to generate an efficient return on assets?
Company
-68%
Industry
31.45%
LPTX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

LPTX earnings per share forecast

What is LPTX's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$1.66
Avg 2 year Forecast
-$1.48
Avg 3 year Forecast
-$1.42

LPTX revenue forecast

What is LPTX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$103.5M
Avg 2 year Forecast
$6.0M
Avg 3 year Forecast
$66.9M

LPTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
LPTX$2.35$7.50+219.15%Strong Buy
CLRB$2.53$20.00+690.51%Strong Buy
BOLD$4.08$23.00+463.73%Strong Buy
BNTC$9.47$23.00+142.87%Strong Buy
ANIX$2.77$7.00+152.71%Buy

Leap Therapeutics Stock Forecast FAQ

Is Leap Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: LPTX) stock is to Strong Buy LPTX stock.

Out of 3 analysts, 1 (33.33%) are recommending LPTX as a Strong Buy, 2 (66.67%) are recommending LPTX as a Buy, 0 (0%) are recommending LPTX as a Hold, 0 (0%) are recommending LPTX as a Sell, and 0 (0%) are recommending LPTX as a Strong Sell.

If you're new to stock investing, here's how to buy Leap Therapeutics stock.

What is LPTX's earnings growth forecast for 2024-2026?

(NASDAQ: LPTX) Leap Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.45%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.78%.

Leap Therapeutics's earnings in 2024 is -$53,371,000.On average, 3 Wall Street analysts forecast LPTX's earnings for 2024 to be -$63,645,283, with the lowest LPTX earnings forecast at -$67,728,101, and the highest LPTX earnings forecast at -$58,544,630. On average, 3 Wall Street analysts forecast LPTX's earnings for 2025 to be -$56,757,679, with the lowest LPTX earnings forecast at -$73,850,416, and the highest LPTX earnings forecast at -$40,560,332.

In 2026, LPTX is forecast to generate -$54,209,266 in earnings, with the lowest earnings forecast at -$83,799,176 and the highest earnings forecast at -$33,672,728.

What is LPTX's revenue growth forecast for 2025-2027?

(NASDAQ: LPTX) Leap Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.21%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.62%.

Leap Therapeutics's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast LPTX's revenue for 2025 to be $3,960,372,024, with the lowest LPTX revenue forecast at $3,960,372,024, and the highest LPTX revenue forecast at $3,960,372,024. On average, 1 Wall Street analysts forecast LPTX's revenue for 2026 to be $229,586,784, with the lowest LPTX revenue forecast at $229,586,784, and the highest LPTX revenue forecast at $229,586,784.

In 2027, LPTX is forecast to generate $2,558,170,741 in revenue, with the lowest revenue forecast at $1,104,695,076 and the highest revenue forecast at $4,011,646,406.

What is LPTX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: LPTX) forecast ROA is -68%, which is lower than the forecast US Biotechnology industry average of 31.45%.

What is LPTX's Price Target?

According to 3 Wall Street analysts that have issued a 1 year LPTX price target, the average LPTX price target is $7.50, with the highest LPTX stock price forecast at $9.00 and the lowest LPTX stock price forecast at $5.50.

On average, Wall Street analysts predict that Leap Therapeutics's share price could reach $7.50 by Jun 28, 2025. The average Leap Therapeutics stock price prediction forecasts a potential upside of 219.15% from the current LPTX share price of $2.35.

What is LPTX's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: LPTX) Leap Therapeutics's current Earnings Per Share (EPS) is -$2.13. On average, analysts forecast that LPTX's EPS will be -$1.66 for 2024, with the lowest EPS forecast at -$1.77, and the highest EPS forecast at -$1.53. On average, analysts forecast that LPTX's EPS will be -$1.48 for 2025, with the lowest EPS forecast at -$1.93, and the highest EPS forecast at -$1.06. In 2026, LPTX's EPS is forecast to hit -$1.42 (min: -$2.19, max: -$0.88).

What is LPTX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: LPTX) forecast ROE is -83.2%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.